Emopamil-Binding Protein Inhibitors for Treating Multiple Sclerosis.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel emopamil-binding protein (EBP) inhibitors, pharmaceutical compositions, use of such compounds in treating multiple sclerosis, and processes for preparing such compounds.